Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_leftBack to Codexis.com

Missed us at TIDES?

Download our talk

Want to know more about RNA?

Download our ebook
  • Blogs
  • Events
  • Careers
  • Investors
  • Search
  • About Us
    • History
    • Leadership Team
    • Facilities
    • ESG
    • Culture and People
  • Expert Solutions

    Pharmaceutical Biocatalysis

    Transform complex, resource-intensive processes into precise, sustainable breakthroughs with biocatalysis that scales from grams to tonnes

    • Enzyme Screening Kits and Panels
    • Tailored Enzymes

    RNA Manufacturing Services

    Evolve beyond solid-phase oligonucleotide synthesis (SPOS) with a modern and efficient approach that delivers higher quality, greater scale, and better manufacturability

    • RNA Ligation Services
    • RNA Sequential Synthesis Services

    Molecular Biology and Diagnostic Applications

    Precision-tuned enzyme solutions enhance fidelity, selectivity, and activity for applications that demand superior performance

    • Bespoke Enzymes
    • R&D Enzyme Services

    Find out more about our solutions

    See our solutions
  • Transformational Technologies
    Transformational Technologies
    • CodeEvolver Technology Platform
    • ECO Synthesis Manufacturing Technology
  • Technical Content
  • Contact Us
Codexis, Inc. IR Overview
  • Overview
  • News & Events
    • News & Events Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • TIDES US
  • Presentations
  • Company Info
    • Company Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Information Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • Stock Information
  • chevron_leftBack to Codexis.com

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • News & Events Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • TIDES US
  • Presentations
  • Company Info
    • Company Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Information Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • News & Events Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • TIDES US
Nov 8, 2022 4:05 pm EST
Codexis to Participate in Upcoming Healthcare Conferences
Nov 3, 2022 4:05 pm EDT
Codexis Reports Third Quarter 2022 Financial Results
Nov 1, 2022 8:00 am EDT
Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel
Oct 20, 2022 4:05 pm EDT
Codexis to Report Third Quarter 2022 Financial Results on November 3
Oct 3, 2022 8:00 am EDT
Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer
Oct 3, 2022 8:00 am EDT
Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors
Sep 14, 2022 4:05 pm EDT
Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field
Aug 4, 2022 4:05 pm EDT
Codexis Reports Second Quarter 2022 Financial Results
Aug 2, 2022 4:05 pm EDT
Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis
Jul 18, 2022 4:05 pm EDT
Codexis Announces CEO Transition Effective August 9, 2022
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap

Let’s redefine what’s possible

Discover the partnership that enables your enzyme-powered innovation — designed for staying power, not just quick wins.

Contact us
  • Jump to
  • About Us
  • Expert Solutions
  • Transformational Technologies
  • Technical Content
  • Blogs
  • Events
  • Careers
  • Investors
  • Help
  • Contact Us
  • Terms of Use
  • Privacy Policy

© 2025 Copyright Codexis

  • Privacy
  • Terms of Use
  • Terms of Sale
  • Disclaimer
  • Patents
  • Trademarks
  • Accessibility Statement

Find us on:

Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.